Gene therapy is reshaping modem medicine, offering the potential for lasting, even curative treatments for a wide range of indications. However, realizing this promise at scale remains one of the industry’s greatest challenges. Viral vector manufacturing continues to face significant bottlenecks in scalability, cost, consistency, and global supply.

In this webinar, Emigdio Reyes, Director of Upstream Process Development, will explore the critical hurdles associated with scaling viral vector production from early-stage development to commercial manufacturing. Attendees will gain insights into key challenges across upstream and downstream development processes, and analytical considerations. Watch this webinar to discover actionable insights to overcome scale-up challenges and advance gene therapies from the bench to patients in need